Login to Your Account

Diabetes Drug Glumetza Gets Approvable Letter From FDA

By Aaron Lorenzo

Wednesday, March 2, 2005
The FDA issued an approvable letter for Glumetza, a once-daily, extended-release version of the diabetes drug metformin, driving up Depomed Inc.'s stock value by 11 percent. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription